Skip to main content
logo
Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
0.8732
-0.0179 (-2.01%)
At close: Jun 26, 2026, 4:00 PM EDT
0.9600
+0.0868 (9.94%)
After-hours: Jun 26, 2026, 7:53 PM EDT

Company Description

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States.

It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states.

The company was founded in 1984 and is based in San Diego, California.

Aethlon Medical, Inc.
Aethlon Medical logo
CountryUnited States
Founded1984
IndustryMedical Devices
SectorHealthcare
Employees9
CEOJames Frakes

Contact Details

Address:
11555 Sorrento Valley Road, Suite 203
San Diego, California 92121
United States
Phone619 941 0360
Websiteaethlonmedical.com

Stock Details

Ticker SymbolAEMD
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyUSD
CIK Code0000882291
CUSIP Number00808Y604
ISIN NumberUS00808Y6041
Employer ID13-3632859
SIC Code3841

Key Executives

NamePosition
James B. Frakes M.B.A.Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer, Secretary and Director
Dr. Steven P. LaRosa M.D.Chief Medical Officer
Michele BombardiereVice President and Controller

Latest SEC Filings

DateTypeTitle
Jun 22, 2026S-1General form for registration of securities under the Securities Act of 1933
Jun 10, 2026S-8Securities to be offered to employees in employee benefit plans
Jun 10, 202610-KAnnual Report
Jun 10, 20268-KCurrent Report
Jun 4, 20268-KCurrent Report
Jun 4, 2026424B5Filing
May 15, 2026SCHEDULE 13G/AFiling
May 5, 2026DRS[Cover] Draft Registration Statement
Mar 17, 20268-KCurrent Report
Feb 23, 20268-KCurrent Report
View All SEC Filings